Research map: CRISPR Screen Reveals Pathways and Factors Driving Tyrosine Kinase Inhibitor Resistance in Hepatocellular Carcinoma

Back to the article

Papers in this map

  1. Inferring tumour purity and stromal and immune cell admixture from expression data · Kosuke Yoshihara · 2013 · 10961 citations · Cited by this paper
  2. Association of the Affordable Care Act With Receipt of Guideline‐Concordant Adjuvant Chemotherapy for Colon and Non‐Small Cell Lung Cancer · 2026 · Related
  3. Improved vectors and genome-wide libraries for CRISPR screening · Neville E. Sanjana · 2014 · 5678 citations · Cited by this paper
  4. Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification · 2026 · Related
  5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial · Masatoshi Kudo · 2018 · 5585 citations · Cited by this paper
  6. Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis · 2026 · Related
  7. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects · Weiwei Tang · 2020 · 1176 citations · Cited by this paper
  8. The Impact of the G8 Score on Survival Outcomes in Patients With Head and Neck Cancer Undergoing Concurrent Radiotherapy With Cetuximab due to Contraindications With Cisplatin · 2026 · Related
  9. Targeted therapy for hepatocellular carcinoma · Ao Huang · 2020 · 788 citations · Cited by this paper
  10. The Zuo Jin Wan Formula Reverses Cisplatin Resistance in Gastric Cancer by Inhibiting the Mitochondrial Translocation of Dynamin‐Related Protein 1 and Its Mediated Mitochondrial Fission and Mitophagy · 2026 · Related
  11. RNA splicing dysregulation and the hallmarks of cancer · Robert K. Bradley · 2023 · 605 citations · Cited by this paper
  12. Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA ‐Dependent Tumor Immune Microenvironment · 2026 · Related
  13. Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy · Luming Yang · 2023 · 363 citations · Cited by this paper
  14. Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy · 2026 · Related
  15. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update · John Dozier Gordan · 2024 · 303 citations · Cited by this paper
  16. Inhibition of the Metalloproteinase ADAMTS5 Suppresses Colorectal Cancer Metastasis via the PEDF /Wnt/β‐Catenin Pathway · 2026 · Related
  17. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity · Sydney X. Lu · 2021 · 297 citations · Cited by this paper
  18. Machine Learning for Prediction of High‐Risk Infections in Patients With Cancer · 2026 · Related
  19. N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways · Jinghan Wang · 2023 · 293 citations · Cited by this paper
  20. Watch and Wait Strategy for Locally Advanced Rectal Cancer: Update From Results of Recent Clinical Trials · 2026 · Related
  21. Endocytosis in cancer and cancer therapy · Blerida Banushi · 2023 · 239 citations · Cited by this paper
  22. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression · Rosa Maria Fontana · 2023 · 209 citations · Cited by this paper
  23. Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer · Antonietta Rosella Farina · 2020 · 144 citations · Cited by this paper
  24. CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma · Yiran Chen · 2022 · 141 citations · Cited by this paper
  25. DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation · Sigrid Uxa · 2019 · 116 citations · Cited by this paper
  26. Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma · Jiaomeng Pan · 2022 · 95 citations · Cited by this paper
  27. The MARCHF6 E3 ubiquitin ligase acts as an NADPH sensor for the regulation of ferroptosis · Kha The Nguyen · 2022 · 92 citations · Cited by this paper
  28. Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation · Jing Wang · 2023 · 91 citations · Cited by this paper
  29. SPSB1-mediated HnRNP A1 ubiquitylation regulates alternative splicing and cell migration in EGF signaling · Feng Wang · 2017 · 80 citations · Cited by this paper
  30. CCT3- LINC00326 axis regulates hepatocarcinogenic lipid metabolism · Jonas Nørskov Søndergaard · 2022 · 75 citations · Cited by this paper
  31. Comparing CRISPR and RNAi-based screening technologies · Benjamin E. Housden · 2016 · 61 citations · Cited by this paper
  32. Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial · Jian Zhou · 2025 · 55 citations · Cited by this paper
  33. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C · Nan Xu · 2023 · 49 citations · Cited by this paper
  34. Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges · Peng Ye · 2021 · 47 citations · Cited by this paper
  35. CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis · Huihui Zhu · 2024 · 31 citations · Cited by this paper
  36. Immunotherapy for hepatocellular carcinoma · Xiaoxia Wang · 2024 · 30 citations · Cited by this paper
  37. ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion · Tianfeng Yang · 2025 · 30 citations · Cited by this paper
  38. RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma · Fanzheng Meng · 2025 · 28 citations · Cited by this paper
  39. UBE2C-induced crosstalk between mono- and polyubiquitination of SNAT2 promotes lymphatic metastasis in bladder cancer · Wenjie Li · 2024 · 27 citations · Cited by this paper

Source: OpenAlex (CC0)